Claudio Mussolino

Dr. Claudio Mussolino is a group leader at the Institute for Transfusion Medicine and Gene Therapy, University Medical Center Freiburg, Germany. His research focuses on genome and epigenome editing of hematopoietic cells for treating immunodeficiencies and cancer. He develops precise, safer editing strategies and innovative approaches to engineer CAR T cells with enhanced resistance to tumor-induced exhaustion.